New findings from the #NEOSTAR trial provide further support for #neoadjuvant #immunotherapy-based treatment as an approach to reduce viable #tumor at #surgery and to improve outcomes in #NSCLC. The combination also was associated with an increase in #immune #cell infiltration and a favorable #gut #microbiome composition.
#Medical #Biology #Microbiology #sflorg
https://www.sflorg.com/2023/03/med03162303.html